List your tool

Head to head · 2026

Cofactor AI vs Tempus AI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Cofactor AI

Cofactor AI reads clinical documentation and payer policies to draft evidence-backed appeals for denied hospital insurance…

4.0Not listed

Visit Cofactor AI (opens Cofactor AI in a new tab)

Tempus AI

Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue

4.3Not listed

Visit Tempus AI (opens Tempus AI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Cofactor AI does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Tempus AI

    4.0 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onCofactor AITempus AI
Our rating4.04.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • AI review of clinical documentation against payer policy
  • Automated appeal letter drafting
  • Denial pattern tracking across payers
  • Eligibility verification automation
  • Evidence gathering from coding guidelines and peer-reviewed studies
  • Machine learning applied to genomic and clinical data for precision treatment matching
  • One of the largest connected libraries of clinical and molecular data
  • Publicly traded on Nasdaq under the ticker TEM
  • Q1 2026 revenue of $348.1M, up 36.1% year over year
  • 2026 revenue guidance raised to $1.59-$1.60 billion
Pros
  • Targets a documented, higher-priced pain point in hospital billing
  • Backed by seed funding from a recognized enterprise VC
  • Appeals are grounded in specific policy and clinical evidence, not templates
  • Publicly reported financials give unusual transparency into scale and growth
  • Massive, growing data library strengthens precision-matching over time
  • Strong, consistent revenue growth across both diagnostics and data segments
Cons
  • Pricing is undisclosed and requires a sales conversation
  • Useful mainly to organizations with claims volume large enough to justify enterprise software
  • Young company (2023) with a limited public track record
  • Pricing runs through insurance billing and enterprise agreements, not published rates
  • Built specifically for precision medicine and oncology, a narrower clinical scope
  • Best suited to institutions already positioned to act on genomic testing results
CompanyCofactor AI, founded 2023Tempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260718. Check the vendor before you buy.

FAQ

Questions people ask

Is Cofactor AI better than Tempus AI?

In our reviews Cofactor AI scores 4.0 and Tempus AI scores 4.3. The better pick depends on the job. Cofactor AI: Cofactor AI reads clinical documentation and payer policies to draft evidence-backed appeals for denied hospital insurance claims. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.

Which is cheaper, Cofactor AI or Tempus AI?

Cofactor AI: see pricing. Tempus AI: see pricing.

Do Cofactor AI and Tempus AI have free plans?

Neither lists a free plan.

More comparisons